New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.
about
P1343
The current state of preclinical prostate cancer animal models.Histotripsy focal ablation of implanted prostate tumor in an ACE-1 canine cancer model.Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258.Zoledronic acid decreased osteolysis but not bone metastasis in a nude mouse model of canine prostate cancer with mixed bone lesions.Canine REIC/Dkk-3 interacts with SGTA and restores androgen receptor signalling in androgen-independent prostate cancer cell lines.The ARF tumor suppressor regulates bone remodeling and osteosarcoma development in mice.Bone metastasis: mechanisms and therapeutic opportunities.Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer.Canine prostate cancer cell line (Probasco) produces osteoblastic metastases in vivoDickkopf-1 (DKK-1) stimulated prostate cancer growth and metastasis and inhibited bone formation in osteoblastic bone metastasesBiochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cellsTumor microenvironment regulates metastasis and metastasis genes of mouse MMTV-PymT mammary cancer cells in vivo.A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancerDevelopment of a brain metastatic canine prostate cancer cell line.Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.Targeting cells of the myeloid lineage attenuates pain and disease progression in a prostate model of bone cancerDrugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.Nuclear localization of parathyroid hormone-related peptide confers resistance to anoikis in prostate cancer cellsParathyroid hormone-related protein drives a CD11b+Gr1+ cell-mediated positive feedback loop to support prostate cancer growth.RCAN1-4 is a thyroid cancer growth and metastasis suppressor.Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions.Estrogen related receptor alpha in castration-resistant prostate cancer cells promotes tumor progression in boneThe Effect of a Histone Deacetylase Inhibitor (AR-42) on Canine Prostate Cancer Growth and Metastasis.A human GRPr-transfected Ace-1 canine prostate cancer model in mice.Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.The canine prostate cancer cell line CHP-1 shows over-expression of the co-chaperone small glutamine-rich tetratricopeptide repeat-containing protein α.Cabozantinib inhibits prostate cancer growth and prevents tumor-induced bone lesions.Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.A novel canine model for prostate cancer.Multimodal μCT/μMR based semiautomated segmentation of rat vertebrae affected by mixed osteolytic/osteoblastic metastases.Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model.Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.3-Phosphoinositide-dependent protein kinase-1/Akt signalling and inhibition in a canine prostate carcinoma cell line.Animal Models of Bone Metastasis.
P2860
Q30418797-39DECFB0-3035-4924-964D-3F89CBE203F1Q30420699-6581E665-78D9-4C16-83FA-F6F184827EC4Q33360441-A2820FB3-1B1F-4A73-B7E5-3712FDC8BEBFQ33705995-B4C6092B-F52C-4A29-A831-2D4A56D98DCEQ33785251-EE609755-F52F-4D0C-8BEB-01D1737F6D1AQ33786905-2FC662CC-0EA8-464B-8357-12127F8D0048Q34025195-4D47DC38-3F95-41B5-82DE-D43EE9FF3CC4Q34333320-24295012-6875-4347-AA48-171A9D0CA18CQ34438300-27F89A9C-F0D0-4FCA-86E4-AE5976623235Q34511164-EB455C5D-4389-4BC9-91FE-A2B6FFC0BCE8Q34541354-DC6EA904-91AD-4E29-AF8C-0AF99014831CQ34921801-A90FD263-018E-4C05-B399-A94DBEA83CBFQ34999463-690603BE-EB5D-4279-96F3-DFD8277786AEQ35116018-6FFF4CED-418C-451D-87CA-A1210E2CF5C8Q35421746-27414930-3777-49FC-B342-B0216D35B01AQ35985440-B41409A5-7315-47E1-BA08-5E7C417FC5A0Q36278275-F99AC7CD-625A-4E79-AB3E-BB79A69F72A3Q36671244-228C3854-1CC8-40CA-8DA6-D749957DCB12Q37338567-B654604D-8124-4C04-9A2E-B58310089366Q37677411-33A898D6-CC45-4628-AFED-E4509E9C4A4EQ37691805-7A29E09A-995E-40F0-81E6-E6608887C755Q37718338-87C6A487-5F81-4123-807C-67E1BF73A70CQ38717140-FCBFF7BD-1781-4400-8804-D2767EB693B1Q38789134-BA9B2478-0A79-4027-9320-8C6EAB14E60EQ38789171-09A136DE-326B-4577-8F3B-270FD59C1AD7Q38804028-530E2AC4-75A1-48EF-B60D-3F5B6A221A78Q39085630-114687FC-C063-4D82-85A3-29CCB81A2DB7Q39096986-60783B32-3837-4467-8665-91DFA575DEACQ39173082-571B36E9-5F3D-4DC1-9456-1AC1D1DD4ACCQ39207608-53CDA9A4-D070-43C4-8968-2DB2F84D405CQ39353664-76C8937F-E34C-4A68-A7E1-D4EAEE6C4347Q39447169-0DE59DB6-F314-4366-B8C5-AF606B13DAD1Q39453306-371A42D6-AB0F-4B31-97A4-3DFF31B41992Q39481257-DE18B4B9-7535-4A03-8270-CF11685E738BQ40165886-32FC4B93-5130-4331-92E0-AB3F5BA6828EQ53489280-DBD42B88-2960-42CB-9A83-8CD183E69789
P2860
New bone formation and osteolysis by a metastatic, highly invasive canine prostate carcinoma xenograft.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
New bone formation and osteoly ...... prostate carcinoma xenograft.
@en
New bone formation and osteoly ...... prostate carcinoma xenograft.
@nl
type
label
New bone formation and osteoly ...... prostate carcinoma xenograft.
@en
New bone formation and osteoly ...... prostate carcinoma xenograft.
@nl
prefLabel
New bone formation and osteoly ...... prostate carcinoma xenograft.
@en
New bone formation and osteoly ...... prostate carcinoma xenograft.
@nl
P2093
P2860
P356
P1433
P1476
New bone formation and osteoly ...... prostate carcinoma xenograft.
@en
P2093
Adrie van Bokhoven
Bruce E LeRoy
Deborah Davis
Murali V P Nadella
Nanda K Thudi
Ramiro E Toribio
Sarah H Tannehill-Gregg
Stephanie Corn
Thomas J Rosol
P2860
P304
P356
10.1002/PROS.20408
P4510
P577
2006-08-01T00:00:00Z